Pascal Deschatelets
2018
In 2018, Pascal Deschatelets earned a total compensation of $1.9M as Chief Operating Officer at Apellis Pharmaceuticals, a 116% increase compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $1,228,700 |
| Salary | $400,000 |
| Other | $8,657 |
| Total | $1,862,357 |
Deschatelets received $1.2M in option awards, accounting for 66% of the total pay in 2018.
Deschatelets also received $225K in bonus, $400K in salary and $8.7K in other compensation.
Rankings
In 2018, Pascal Deschatelets' compensation ranked 6,110th out of 14,244 executives tracked by ExecPay. In other words, Deschatelets earned more than 57.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,110 out of 14,244 | 57th |
Division Manufacturing | 2,332 out of 5,765 | 60th |
Major group Chemicals And Allied Products | 872 out of 2,128 | 59th |
Industry group Drugs | 730 out of 1,817 | 60th |
Industry Pharmaceutical Preparations | 569 out of 1,391 | 59th |
Source: SEC filing on April 30, 2019.
Deschatelets' colleagues
We found four more compensation records of executives who worked with Pascal Deschatelets at Apellis Pharmaceuticals in 2018.
News
Apellis Pharmaceuticals CEO Cedric Francois' 2021 pay slips 2% to $9.1M
April 20, 2022
Apellis Pharmaceuticals CEO Cedric Francois' 2020 pay jumps 117% to $9.3M
April 22, 2021
Apellis Pharmaceuticals CEO Cedric Francois' 2019 pay rises 5% to $4.3M
April 22, 2020
Apellis Pharmaceuticals CEO Cedric Francois' 2018 pay jumps 145% to $4.1M
April 30, 2019